MWA
DMTK

Marshall Wace Asia’s DermTech, Inc. Common Stock DMTK Stock Holding History

Marshall Wace Asia’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$17.8M Buy
+554,949
New +$19.5M 0.42% 63

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace Asia's DMTK Position: Q3 2021 in Review

Marshall Wace Asia opened a new position in DermTech, Inc. Common Stock (DMTK) in Q3 2021: 554,949 shares worth $17.8M. The stake represents 0.42% of the portfolio and ranks #63 among its holdings.

162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Marshall Wace Asia held 554,949 shares of DermTech, Inc. Common Stock worth $17.8M as of Q3 2021.
  • DermTech, Inc. Common Stock was a new Marshall Wace Asia position in Q3 2021.
  • DermTech, Inc. Common Stock made up 0.42% of Marshall Wace Asia's portfolio in Q3 2021, its #63 holding.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.